Title Phenotype Institution Algorithm Type Total Cases Total Controlssort descending PPV Sensitivity
CHOP Part II- RESPONDERS Epilepsy/Antiepileptic drug response algorithm Case Only 0.85
Validation Cardiorespiratory Fitness Algorithm (eMERGE Mayo Network Phenotype) Geisinger Case Only
Anxiety - Marshfield Anxiety algorithm Marshfield Clinic Research Institute Case Only
Demonstration Project Crohn's Disease Implementation Crohn's Disease - Demonstration Project Vanderbilt University Case, Control 1.00, 1.00
Autism Validation Autism CHOP Case Only 50 0.85 0.74
CCHMC - PART 1 Epilepsy/Antiepileptic drug response algorithm Cincinnati Children's Hospital Medical Center Case Only 129 0.86
NU NAFLD implementation Non-alcoholic fatty liver disease (NALFD) & Alcoholic Fatty Liver Disease (ALD) Northwestern University Case, Control 57
Mayo Breast CA Implementation Breast Cancer Mayo Clinic Case, Control
Lipids Marshfield Implementation Lipids Marshfield Clinic Research Foundation Case Only 0.79 0.95
Harvard Cardiorespiratory Fitness Algorithm (eMERGE Mayo Network Phenotype) Partners Healthcare Case Only 1,103
Autoimmune Disease Phenotype_Mayo implementation Autoimmune Disease Phenotype Mayo Clinic Case, Control
Anxiety_VUMC Anxiety algorithm VUMC Case, Control
Mayo SLE Implementation SLE (Systemic Lupus Erythematosus) using SLICC (Systemic Lupus Internation Collaborating Clinics) Criteria Mayo Clinic Case, Control 0 0 0.00, 0.00 0.00
CHOP Post-event Pain Post-event Pain algorithm CHOP Case, Control 99 2 0.96
Early Childhood Obesity Implementation - Columbia Severe Early Childhood Obesity Columbia University Case, Control 2 3
Validation of Asthma algorithm - Geisinger Asthma Geisinger Case, Control 10 10 1.00, 1.00
Marshfield C-diff implementation Clostridium Difficile Colitis Marshfield Clinic Research Foundation Case, Control 21 10 1.00, 1.00
Marshfield Zoster implementation Herpes Zoster Marshfield Clinic Research Foundation Case, Control 10 10 1.00, 1.00
Appendicitis Case 1, Control Appendicitis Cincinnati Children's Hospital Medical Center Case, Control 15 20 0.93, 1.00
Geisinger c.Diff eMERGE3 Implementation Clostridium Difficile Colitis Geisinger Case, Control 20 20 1.00, 1.00 1.00, 1.00
Marshfield AAA implementation Abdominal Aortic Aneurysm ( AAA ) Marshfield Clinic Research Foundation Case, Control 25 22 1.00, 1.00
Statin and MACE Mount Sinai Implementation Statins and MACE Mount Sinai Case Only 52 25 0.96, 1.00 1.00, 1.00
Group Health/University of Washington CRC Validation Colorectal Cancer (CRC) GH/UW Case, Control 25 25 0.92, 1.00 1.00, 1.00
Marshfield ACE-I cough implentation ACE Inhibitor (ACE-I) induced cough Marshfield Clinic Research Foundation Case, Control 25 25 1.00, 0.96
Implementation For Phase 3 eMERGE Electronic Health Record-based Phenotyping Algorithm for Familial Hypercholesterolemia Geisinger Case, Control 25 25 1.00, 0.96

Pages